# US 2006/0078900 A1 · Molecular toxicology modeling

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0078900 A1
- Document ID: US20060078900A1
- Status: Published application
- Kind: A1
- Application number: 11/036,196
- Filed: 2005-01-18
- Published: 2006-04-13
- Earliest claimed: 2001-05-22
- Assignees: Gene Logic, Inc.
- Inventors: Donna Mendrick; Mark Porter; Kory Johnson; Brandon Higgs; Arthur Castle; Michael Elashoff
- Web page: https://patentgrep.com/patent/US20060078900A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- G16B 25/10: Gene or protein expression profiling; Expression-ratio estimation or normalisation
- C12Q 2600/142: Toxicological screening, e.g. expression profiles which identify toxicity
- C12Q 2600/158: Expression markers
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- Y10S 707/99945: Object-oriented database structure processing
- Y10S 707/99948: Application of database or data structure, e.g. distributed, multimedia, or image
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- Y10S: TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS

## Abstract

The present invention is based on the elucidation of the global changes in gene expression and the identification of toxicity markers in tissues or cells exposed to a known renal toxin. The genes may be used as toxicity markers in drug screening and toxicity assays. The invention includes a database of genes characterized by toxin-induced differential expression that is designed for use with microarrays and other solid-phase probes.

## Claims

### Claim 1

A method of predicting at least one toxic effect of a compound, comprising:
(a) preparing a gene expression profile of a tissue or cell sample exposed to the compound; and
(b) comparing the gene expression profile to a database comprising at least part of the data or information of Tables 1-5.

### Claim at position 2

2-59. (canceled)
